INS and Obesity: Adiponectin, an adipokine, enhances insulin sensitivity and promotes anti-inflammatory and antifibrotic activities [7]; however, studies show that adiponectin is reduced in patients with obesity and coronary artery disease, suggesting its crucial role in obesity-associated cardiovascular diseases [7,8].